ABBV vs MDT
By Alex · Tickerpine
AbbVie Inc. vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | ABBV | MDT |
|---|---|---|
| Price | $295.03 | $102.86 |
| Market cap | $521.50B | $131.57B |
| P/E ratio | 50.7 | 25.3 |
| ROE | — | 10.65% |
| Profit margin | 15.67% | 13.93% |
| Revenue growth | 10.30% | 13.70% |
| Dividend yield | 2.35% | 2.80% |
| Beta | 0.19 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
ABBV vs MDT in plain English
- ABBV is the bigger company — about 4.0× the market cap of MDT.
- MDT is cheaper on earnings (P/E 25.3 vs 50.7).
- MDT is growing revenue faster (14% vs 10%).
- MDT has the higher dividend yield (2.80% vs 2.35%).
How would $1,000 have done in each?
ABBV return calculator
See what $1,000 in AbbVie Inc. would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.